Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof

Details for Australian Patent Application No. 2004226049 (hide)

International Classifications

Event Publications

27 October 2005 PCT application entered the National Phase

PCT publication WO2004/087669 Priority application(s): WO2004/087669

20 September 2007 Assignment before Grant

Taisho Pharmaceutical Co. Ltd; Arena Pharmaceuticals Inc. The application has been assigned to Arena Pharmaceuticals Inc.

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.